United States Conjunctivitis Market Report & Forecast 2021-2027

Publisher Name :
Date: 13-Sep-2021
No. of pages: 94
Inquire Before Buying

United States Conjunctivitis Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Conjunctivitis Market Segment Percentages, By Type, 2020 (%)

- Antibiotic

- Pills

- Ointment

United States Conjunctivitis Market, By End User, 2016-2021, 2022-2027 ($ Millions) & (K Units)

United States Conjunctivitis Market Segment Percentages, By End User, 2020 (%)

- Newborns

- Children

- Adults

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Conjunctivitis revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Conjunctivitis revenues share in United States market, 2020 (%)

Key companies Conjunctivitis sales in United States market, 2016-2021 (Estimated), (K Units)

Key companies Conjunctivitis sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Novartis (CH)

- Santen Pharmaceutical (JP)

- Bausch & Lomb (US)

- Allergan (US)

- Sun Pharmaceutical (ID)

- Akorn (US)

- Freda (CN)

- Sinqi (CN)

- Univision (CN)

United States Conjunctivitis Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Conjunctivitis Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by End User
1.3 United States Conjunctivitis Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Conjunctivitis Overall Market Size
2.1 United States Conjunctivitis Market Size: 2021 VS 2027
2.2 United States Conjunctivitis Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Conjunctivitis Sales: 2016-2027
3 Company Landscape
3.1 Top Conjunctivitis Players in United States Market
3.2 Top United States Conjunctivitis Companies Ranked by Revenue
3.3 United States Conjunctivitis Revenue by Companies
3.4 United States Conjunctivitis Sales by Companies
3.5 United States Conjunctivitis Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Conjunctivitis Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Conjunctivitis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Conjunctivitis Players in United States Market
3.8.1 List of Tier 1 Conjunctivitis Companies in United States
3.8.2 List of Tier 2 and Tier 3 Conjunctivitis Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Conjunctivitis Market Size Markets, 2021 & 2027
4.1.2 Antibiotic
4.1.3 Pills
4.1.4 Ointment
4.2 By Type - United States Conjunctivitis Revenue & Forecasts
4.2.1 By Type - United States Conjunctivitis Revenue, 2016-2021
4.2.2 By Type - United States Conjunctivitis Revenue, 2022-2027
4.2.3 By Type - United States Conjunctivitis Revenue Market Share, 2016-2027
4.3 By Type - United States Conjunctivitis Sales & Forecasts
4.3.1 By Type - United States Conjunctivitis Sales, 2016-2021
4.3.2 By Type - United States Conjunctivitis Sales, 2022-2027
4.3.3 By Type - United States Conjunctivitis Sales Market Share, 2016-2027
4.4 By Type - United States Conjunctivitis Price (Manufacturers Selling Prices), 2016-2027
5 Sights by End User
5.1 Overview
5.1.1 By End User - United States Conjunctivitis Market Size, 2021 & 2027
5.1.2 Newborns
5.1.3 Children
5.1.4 Adults
5.2 By End User - United States Conjunctivitis Revenue & Forecasts
5.2.1 By End User - United States Conjunctivitis Revenue, 2016-2021
5.2.2 By End User - United States Conjunctivitis Revenue, 2022-2027
5.2.3 By End User - United States Conjunctivitis Revenue Market Share, 2016-2027
5.3 By End User - United States Conjunctivitis Sales & Forecasts
5.3.1 By End User - United States Conjunctivitis Sales, 2016-2021
5.3.2 By End User - United States Conjunctivitis Sales, 2022-2027
5.3.3 By End User - United States Conjunctivitis Sales Market Share, 2016-2027
5.4 By End User - United States Conjunctivitis Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Novartis (CH)
6.1.1 Novartis (CH) Corporation Information
6.1.2 Novartis (CH) Overview
6.1.3 Novartis (CH) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.1.4 Novartis (CH) Conjunctivitis Product Description
6.1.5 Novartis (CH) Recent Developments
6.2 Santen Pharmaceutical (JP)
6.2.1 Santen Pharmaceutical (JP) Corporation Information
6.2.2 Santen Pharmaceutical (JP) Overview
6.2.3 Santen Pharmaceutical (JP) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.2.4 Santen Pharmaceutical (JP) Conjunctivitis Product Description
6.2.5 Santen Pharmaceutical (JP) Recent Developments
6.3 Bausch & Lomb (US)
6.3.1 Bausch & Lomb (US) Corporation Information
6.3.2 Bausch & Lomb (US) Overview
6.3.3 Bausch & Lomb (US) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.3.4 Bausch & Lomb (US) Conjunctivitis Product Description
6.3.5 Bausch & Lomb (US) Recent Developments
6.4 Allergan (US)
6.4.1 Allergan (US) Corporation Information
6.4.2 Allergan (US) Overview
6.4.3 Allergan (US) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.4.4 Allergan (US) Conjunctivitis Product Description
6.4.5 Allergan (US) Recent Developments
6.5 Sun Pharmaceutical (ID)
6.5.1 Sun Pharmaceutical (ID) Corporation Information
6.5.2 Sun Pharmaceutical (ID) Overview
6.5.3 Sun Pharmaceutical (ID) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.5.4 Sun Pharmaceutical (ID) Conjunctivitis Product Description
6.5.5 Sun Pharmaceutical (ID) Recent Developments
6.6 Akorn (US)
6.6.1 Akorn (US) Corporation Information
6.6.2 Akorn (US) Overview
6.6.3 Akorn (US) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.6.4 Akorn (US) Conjunctivitis Product Description
6.6.5 Akorn (US) Recent Developments
6.7 Freda (CN)
6.7.1 Freda (CN) Corporation Information
6.7.2 Freda (CN) Overview
6.7.3 Freda (CN) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.7.4 Freda (CN) Conjunctivitis Product Description
6.7.5 Freda (CN) Recent Developments
6.8 Sinqi (CN)
6.8.1 Sinqi (CN) Corporation Information
6.8.2 Sinqi (CN) Overview
6.8.3 Sinqi (CN) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.8.4 Sinqi (CN) Conjunctivitis Product Description
6.8.5 Sinqi (CN) Recent Developments
6.9 Univision (CN)
6.9.1 Univision (CN) Corporation Information
6.9.2 Univision (CN) Overview
6.9.3 Univision (CN) Conjunctivitis Sales and Revenue in United States Market (2016-2021)
6.9.4 Univision (CN) Conjunctivitis Product Description
6.9.5 Univision (CN) Recent Developments
7 United States Conjunctivitis Production Capacity, Analysis
7.1 United States Conjunctivitis Production Capacity, 2016-2027
7.2 Conjunctivitis Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Conjunctivitis Supply Chain Analysis
9.1 Conjunctivitis Industry Value Chain
9.2 Conjunctivitis Upstream Market
9.3 Conjunctivitis Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Conjunctivitis Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Conjunctivitis in United States Market
Table 2. Top Conjunctivitis Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Conjunctivitis Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Conjunctivitis Revenue Share by Companies, 2016-2021
Table 5. United States Conjunctivitis Sales by Companies, (K Units), 2016-2021
Table 6. United States Conjunctivitis Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Conjunctivitis Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Conjunctivitis Product Type
Table 9. List of Tier 1 Conjunctivitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Conjunctivitis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Antibiotic
Table 12. Major Manufacturers of Pills
Table 13. By Type - United States Conjunctivitis Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Conjunctivitis Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Conjunctivitis Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Conjunctivitis Sales (K Units), 2016-2021
Table 17. By Type - United States Conjunctivitis Sales (K Units), 2022-2027
Table 18. By End User - United States Conjunctivitis Revenue, (US$, Mn), 2021 VS 2027
Table 19. By End User - United States Conjunctivitis Revenue (US$, Mn), 2016-2021
Table 20. By End User - United States Conjunctivitis Revenue (US$, Mn), 2022-2027
Table 21. By End User - United States Conjunctivitis Sales (K Units), 2016-2021
Table 22. By End User - United States Conjunctivitis Sales (K Units), 2022-2027
Table 23. Novartis (CH) Corporation Information
Table 24. Novartis (CH) Description and Major Businesses
Table 25. Novartis (CH) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Novartis (CH) Conjunctivitis Product
Table 27. Novartis (CH) Recent Developments
Table 28. Santen Pharmaceutical (JP) Corporation Information
Table 29. Santen Pharmaceutical (JP) Description and Major Businesses
Table 30. Santen Pharmaceutical (JP) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Santen Pharmaceutical (JP) Conjunctivitis Product
Table 32. Santen Pharmaceutical (JP) Recent Developments
Table 33. Bausch & Lomb (US) Corporation Information
Table 34. Bausch & Lomb (US) Description and Major Businesses
Table 35. Bausch & Lomb (US) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Bausch & Lomb (US) Conjunctivitis Product
Table 37. Bausch & Lomb (US) Recent Developments
Table 38. Allergan (US) Corporation Information
Table 39. Allergan (US) Description and Major Businesses
Table 40. Allergan (US) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Allergan (US) Conjunctivitis Product
Table 42. Allergan (US) Recent Developments
Table 43. Sun Pharmaceutical (ID) Corporation Information
Table 44. Sun Pharmaceutical (ID) Description and Major Businesses
Table 45. Sun Pharmaceutical (ID) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Sun Pharmaceutical (ID) Conjunctivitis Product
Table 47. Sun Pharmaceutical (ID) Recent Developments
Table 48. Akorn (US) Corporation Information
Table 49. Akorn (US) Description and Major Businesses
Table 50. Akorn (US) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Akorn (US) Conjunctivitis Product
Table 52. Akorn (US) Recent Developments
Table 53. Freda (CN) Corporation Information
Table 54. Freda (CN) Description and Major Businesses
Table 55. Freda (CN) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Freda (CN) Conjunctivitis Product
Table 57. Freda (CN) Recent Developments
Table 58. Sinqi (CN) Corporation Information
Table 59. Sinqi (CN) Description and Major Businesses
Table 60. Sinqi (CN) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Sinqi (CN) Conjunctivitis Product
Table 62. Sinqi (CN) Recent Developments
Table 63. Univision (CN) Corporation Information
Table 64. Univision (CN) Description and Major Businesses
Table 65. Univision (CN) Conjunctivitis Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Univision (CN) Conjunctivitis Product
Table 67. Univision (CN) Recent Developments
Table 68. Conjunctivitis Production Capacity (K Units) of Key Manufacturers in United States Market, 2019-2021 (K Units)
Table 69. United States Conjunctivitis Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Conjunctivitis Market Opportunities & Trends in United States Market
Table 71. Conjunctivitis Market Drivers in United States Market
Table 72. Conjunctivitis Market Restraints in United States Market
Table 73. Conjunctivitis Raw Materials
Table 74. Conjunctivitis Raw Materials Suppliers in United States Market
Table 75. Typical Conjunctivitis Downstream
Table 76. Conjunctivitis Downstream Clients in United States Market
Table 77. Conjunctivitis Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Conjunctivitis Product Picture
Figure 2. Conjunctivitis Segment by Type
Figure 3. Conjunctivitis Segment by End User
Figure 4. United States Conjunctivitis Market Overview: 2020
Figure 5. United States Conjunctivitis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Conjunctivitis Revenue, 2016-2027 (US$, Mn)
Figure 7. Conjunctivitis Sales in United States Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Conjunctivitis Revenue in 2020
Figure 9. Antibiotic Product Picture
Figure 10. Pills Product Picture
Figure 11. Ointment Product Picture
Figure 12. By Type - United States Conjunctivitis Sales Market Share, 2016-2027
Figure 13. By Type - United States Conjunctivitis Revenue Market Share, 2016-2027
Figure 14. By Type - United States Conjunctivitis Price (USD/Unit), 2016-2027
Figure 15. Newborns
Figure 16. Children
Figure 17. Adults
Figure 18. By End User - United States Conjunctivitis Sales Market Share, 2016-2027
Figure 19. By End User - United States Conjunctivitis Revenue Market Share, 2016-2027
Figure 20. By End User - United States Conjunctivitis Price (USD/Unit), 2016-2027
Figure 21. Novartis (CH) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Santen Pharmaceutical (JP) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bausch & Lomb (US) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Allergan (US) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Sun Pharmaceutical (ID) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Akorn (US) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Freda (CN) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Sinqi (CN) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Univision (CN) Conjunctivitis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. United States Conjunctivitis Production Capacity (K Units), 2016-2027
Figure 31. Conjunctivitis Industry Value Chain
Figure 32. Marketing Channels
  • Global Artificial Tears Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91
    Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......
  • Global Contact Lens Solution Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96
    Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......
  • Global Latanoprost Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82
    Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......
  • Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......
  • Global Dry Eye Syndrome Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......
  • Global Eye Drops & Lubricants Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......
  • Global Conjunctivitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Contact Lens Solution Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......
  • Global Latanoprost Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs